Cancer
Revolutionizing ovarian cancer treatment with adaptive PARP inhibitor therapy
TAMPA, Fla. — Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop...
Chemotherapy disrupts gut microbiome in patients with breast cancer
COLUMBUS, Ohio – Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with...
New metabolic signature predicts immunotherapy response and survival in cancer patients
In an innovative study published in a leading scientific journal, an international team of researchers led by Prof. Wangjun Liao from...
For healthy adults, taking multivitamins daily is not associated with a lower risk of death
What: A large analysis of data from nearly 400,000 healthy U.S. adults followed for more than 20 years has found no...
Improving prostate cancer screening for transgender women
Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the...
New survey from NCCN finds cancer drug shortage management remains a moving target, impacting clinical trials
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit alliance of leading cancer centers—is publishing new results for...
Scientists discover high-risk form of endometrial cancer — and how to test for it — using AI
A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the...
Korea University identifies novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in HER2-positive breast cancer
HER2-positive breast cancer, known for its aggressive nature due to the overexpression of the HER2 protein, poses significant challenges in...
MSK Research Highlights, June 25, 2024
New research from Memorial Sloan Kettering Cancer Center (MSK) helped develop a machine-learning tool to help find cancer cells that...
Combined determination of CYFRA 21-1 and CXCR1/2 levels for detecting recurrence in stage III squamous cell lung carcinoma
Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!